CUBE — Cube Labs SpA Share Price
Last trade - 00:00- €36.06m
- €37.27m
- €1.00m
- 18
- 36
- 62
- 29
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.64 | ||
| Price to Tang. Book | 0.65 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 29.56 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -0.51% | ||
| Return on Equity | -0.73% | ||
| Operating Margin | -24.89% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.28 | 0.52 | 0.91 | 1.11 | 1 | 1.2 | 1.4 | 37.02% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +60.72 | -2.33 | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cube Labs SpA is an Italy-based venture builder in the healthcare technology industry. The Company creates companies from R&D stage and provides entrepreneurial and operational support into healthcare management and technology solutions. It also promotes and implements results of scientific research in the field of human health, biotechnology and nanotechnology. The Company operates globally.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- July 22nd, 2013
- Public Since
- March 21st, 2023
- No. of Employees
- 2
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
- Borsa Italiana
- Shares in Issue
- 17,852,500
- Address
- Giulio Caccini, 1, ROMA, 00186
- Web
- https://cube-labs.com/
- Phone
- Auditors
- Ria Grant Thornton SpA
Similar to CUBE
Aatech SpA Sb
Borsa Italiana
ABC SpA SB
Borsa Italiana
Ambromobiliare SpA
Borsa Italiana
Anima Holding SpA
Borsa Italiana
Azimut Holding SpA
Borsa Italiana
FAQ
As of Today at 13:06 UTC, shares in Cube Labs SpA are trading at €2.02. This share price information is delayed by 15 minutes.
Shares in Cube Labs SpA last closed at €2.02 and the price had moved by -0.49% over the past 365 days. In terms of relative price strength the Cube Labs SpA share price has underperformed the FTSE Global All Cap Index by -8.57% over the past year.
The overall consensus recommendation for Cube Labs SpA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Cube Labs SpA does not currently pay a dividend.
Cube Labs SpA does not currently pay a dividend.
Cube Labs SpA does not currently pay a dividend.
To buy shares in Cube Labs SpA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €2.02, shares in Cube Labs SpA had a market capitalisation of €36.06m.
Here are the trading details for Cube Labs SpA:
- Country of listing: Italy
- Exchange: MIL
- Ticker Symbol: CUBE
Based on an overall assessment of its quality, value and momentum Cube Labs SpA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Cube Labs SpA is €2.00. That is 0.99% below the last closing price of €2.02.
Analysts covering Cube Labs SpA currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cube Labs SpA. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -16.42%.
As of the last closing price of €2.02, shares in Cube Labs SpA were trading +4.56% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Cube Labs SpA PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €2.02.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Cube Labs SpA's directors